Cytotoxicity and apoptotic gene expression in an in vitro model of the blood–brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles-Reference-Cited by-同舟云学术

Cytotoxicity and apoptotic gene expression in an in vitro model of the blood–brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles

Published:2016-02-05 Issue:7 Volume:24 Page:635-644
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Hall Andrew M.¹²,Hemmer Ruth¹,Spaulding Robert¹,Wetzel Hanna N.¹,Curcio Joseph¹,Sabel Bernhard A.³,Henrich-Noack Petra³,Pixley Sarah⁴,Hopkins Tracy⁴,Boyce Richard L.¹,Schultheis Patrick J.¹,Haik Kristi L.¹

Affiliation:

1. Department of Biological Sciences, Northern Kentucky University, Highland Heights, KY, USA;

2. Department of Chemistry, Northern Kentucky University, Highland Heights, KY, USA;

3. Institute of Medical Psychology, Otto-von-Guericke University, Magdeburg, Germany;

4. Molecular and Cellular Physiology Department, University of Cincinnati Medical Center, Cincinnati, OH, USA

Funder

National Center for Research Resources

National Institute of Neurological Disorders and Stroke

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.3109/1061186X.2015.1132222

Reference58 articles.

1. Brain Drug Targeting

2. Nano-interventions for neurodegenerative disorders

3. Tight junctions of the blood–brain barrier

4. Alzheimer's disease drug development and the problem of the blood‐brain barrier

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspects of Nanomedicines’ Safety and Nanotoxicity for Brain-Targeted Drug Delivery;Smart Nanomaterials Technology;2024

2. Current Status and Progress in Stem Cell Therapy for Intracerebral Hemorrhage;Translational Stroke Research;2023-11-25

3. From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier;Advanced Therapeutics;2020-07-26

4. Pharmaceutical Targeting of the Brain;Current Pharmaceutical Design;2016-11-11